[go: up one dir, main page]

PT2153260T - Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma - Google Patents

Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma

Info

Publication number
PT2153260T
PT2153260T PT87562112T PT08756211T PT2153260T PT 2153260 T PT2153260 T PT 2153260T PT 87562112 T PT87562112 T PT 87562112T PT 08756211 T PT08756211 T PT 08756211T PT 2153260 T PT2153260 T PT 2153260T
Authority
PT
Portugal
Prior art keywords
processes
preparation
composition
same
biologically active
Prior art date
Application number
PT87562112T
Other languages
English (en)
Inventor
Draghia-Akli Ruxandra
Hebel Henry
Cai Ying
Original Assignee
Vgxi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vgxi Inc filed Critical Vgxi Inc
Publication of PT2153260T publication Critical patent/PT2153260T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/12Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/20Partition-, reverse-phase or hydrophobic interaction chromatography
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Sustainable Development (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT87562112T 2007-05-23 2008-05-23 Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma PT2153260T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93979207P 2007-05-23 2007-05-23

Publications (1)

Publication Number Publication Date
PT2153260T true PT2153260T (pt) 2017-04-24

Family

ID=39669869

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87562112T PT2153260T (pt) 2007-05-23 2008-05-23 Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma

Country Status (11)

Country Link
US (3) US20090004716A1 (pt)
EP (1) EP2153260B1 (pt)
JP (1) JP5793726B2 (pt)
KR (1) KR101497728B1 (pt)
CN (2) CN101702938A (pt)
AU (1) AU2008256681B2 (pt)
CA (1) CA2685069C (pt)
ES (1) ES2622418T3 (pt)
HR (1) HRP20170233T1 (pt)
PT (1) PT2153260T (pt)
WO (1) WO2008148010A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101909635B (zh) 2008-01-11 2014-09-17 Vgx药品有限责任公司 针对多种登革病毒亚型的新颖疫苗
US7932356B1 (en) * 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
EP2632261B1 (en) 2010-10-26 2016-07-13 Presidio Pharmaceuticals, Inc. Inhibitors of hepatitis c virus
EA202092990A3 (ru) 2011-02-11 2021-07-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
US9238679B2 (en) 2011-02-11 2016-01-19 The Trustees Of The University Of Pennslyvania Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
US10883100B2 (en) * 2011-03-29 2021-01-05 Phynexus, Inc Devices and methods for plasmid purification
US11274292B2 (en) 2011-03-29 2022-03-15 Phynexus, Inc. Devices and methods for plasmid purification
CN102212466B (zh) * 2011-04-11 2013-08-28 中国人民解放军军事医学科学院放射与辐射医学研究所 制备质粒dna的碱裂解系统及组合系统
JP6117781B2 (ja) 2011-07-11 2017-04-19 イノビオ ファーマシューティカルズ,インコーポレイティド 交差防御性アレナウイルスワクチンおよびそれらの使用方法
US9556427B2 (en) * 2013-02-27 2017-01-31 Syngenta Participations Ag Methods and compositions for preparation of nucleic acids
KR20150130284A (ko) 2013-03-15 2015-11-23 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 암 백신 및 이를 이용한 치료 방법
KR101718045B1 (ko) * 2015-09-07 2017-03-20 엘지전자 주식회사 스크롤 압축기
CA3013718C (en) 2016-02-05 2023-09-26 Jian Yan Cancer vaccines and methods of treatment using the same
AU2018383663B2 (en) 2017-12-13 2023-12-21 Inovio Pharmaceuticals, Inc. Cancer vaccines targeting BORIS and uses thereof
CN111741772A (zh) 2017-12-13 2020-10-02 艾诺奥医药品有限公司 靶向muc16的癌症疫苗和其用途
MX2020006226A (es) 2017-12-13 2020-11-18 Inovio Pharmaceuticals Inc Vacunas contra el cancer dirigidas a mesotelina y usos de estas.
CA3083532C (en) 2017-12-13 2023-09-05 Inovio Pharmaceuticals, Inc. Cancer vaccines targeting prame and uses thereof
TWI903214B (zh) * 2018-05-02 2025-11-01 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
MX2020012910A (es) * 2018-05-31 2021-05-27 Vgxi Inc Aparato de espiral de lisis y usos del mismo para el aislamiento y purificacion de polinucleotidos.
EP3594338A1 (en) * 2018-07-12 2020-01-15 Kaneka Eurogentec SA Method and apparatus for the purification of extra-chromosomal nucleic acid sequences
CN115404154A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的装置
CN114933960A (zh) * 2022-07-03 2022-08-23 苏州谱博分析技术有限公司 一种连续流细菌破碎与澄清装置
CN116855359A (zh) * 2023-07-11 2023-10-10 江苏谱新生物医药有限公司 一种质粒碱裂解的系统和方法
JP2026006022A (ja) * 2024-06-28 2026-01-16 キヤノン株式会社 細胞処理方法、及び細胞処理装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197553B1 (en) * 1994-07-15 2001-03-06 Merck & Co., Inc. Method for large scale plasmid purification
AR003122A1 (es) * 1995-05-19 1998-07-08 Merck & Co Inc Un proceso para aislacion y purificacion de plasmidos en fermentadores de gran escala y el adn aislado y purificado obtenido mediante dicho proceso.
WO2001046215A1 (en) * 1999-12-22 2001-06-28 Merck & Co., Inc. Process for the scaleable purification of plasmid dna
PT102491B (pt) * 2000-07-10 2003-02-28 Inst Superior Tecnico Processo para producao e purificacao de dna plasmidico
US20030197936A1 (en) * 2002-04-18 2003-10-23 The Board Of Trustees Of The Leland Stanford Junior University Tunable polarization mode dispersion compensation using multi-layered reflector
GB0210899D0 (en) * 2002-05-13 2002-06-19 Aston Photonic Tech Ltd Dispersion compensator
CA2498518A1 (en) * 2002-09-13 2004-03-25 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
EP1462519A1 (en) * 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
ES2748130T3 (es) * 2003-05-30 2020-03-13 Vgxi Inc Dispositivos y métodos para la producción de un biomaterial
US7221827B2 (en) * 2003-09-08 2007-05-22 Aegis Semiconductor, Inc. Tunable dispersion compensator
JP2007505613A (ja) * 2003-09-17 2007-03-15 センテリオン 医薬品グレードのプラスミドdnaの作成方法
SE0400490D0 (sv) * 2004-02-26 2004-02-26 Amersham Biosciences Ab Plasmid purification
NZ549835A (en) * 2004-04-19 2008-12-24 Centelion Method for purifying plasmid DNA
CN100439497C (zh) * 2006-05-26 2008-12-03 吉林大学 一种适用于大规模生产质粒dna的纯化方法

Also Published As

Publication number Publication date
EP2153260B1 (en) 2017-01-25
US20090004716A1 (en) 2009-01-01
HRP20170233T1 (hr) 2017-06-02
WO2008148010A1 (en) 2008-12-04
CN101702938A (zh) 2010-05-05
KR20100017884A (ko) 2010-02-16
US20200017819A1 (en) 2020-01-16
AU2008256681A1 (en) 2008-12-04
JP5793726B2 (ja) 2015-10-14
AU2008256681B2 (en) 2014-07-31
US11453855B2 (en) 2022-09-27
WO2008148010A9 (en) 2013-10-24
WO2008148010A8 (en) 2010-02-18
CA2685069A1 (en) 2008-12-04
ES2622418T3 (es) 2017-07-06
CA2685069C (en) 2019-01-15
CN105567672A (zh) 2016-05-11
JP2010527617A (ja) 2010-08-19
EP2153260A1 (en) 2010-02-17
KR101497728B1 (ko) 2015-03-03
US20230002720A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
PT2153260T (pt) Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma
BRPI0815079A2 (pt) Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto
EP2131848A4 (en) COMPOSITIONS AND METHODS FOR REINFORCED ACTIVITY OF BIOLOGICAL ACTIVE MOLECULES
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!
BRPI0916235A2 (pt) composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
BRPI0820665A2 (pt) compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0920955A2 (pt) processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica
EP2054405A4 (en) New biarylbenzimidazole derivatives and pharmaceutical composition containing them
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
EP2475649A4 (en) INDENO DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH
BRPI0908208A2 (pt) Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
FR2926996B1 (fr) Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
BRPI0821327A2 (pt) Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêutica
BRPI0905687A2 (pt) "composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto"
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung